Research initiative on joint "diagnostic and therapeutic" model to fight against antimicrobial resistance

Since 2020, bioMérieux has supported fundamental and applied research in health economics at TSE, focusing on the challenges of antibiotic resistance and the economics of diagnostics. The company was thus one of the first partners of the TSE Health Center.

In 2024, bioMérieux renewed its commitment to further develop economic research focused on a combined “diagnostic and therapeutic” model. This approach is based on a dual perspective, covering both primary care and hospital-based medicine.

Activities

The research initiative, combines several types of activities:

• Conducting research on identified issues,
• Presenting the research at scientific conferences or events for policymakers,
• Producing materials that explain academic research in layman’s terms for policymakers.

The initiative draws in particular on the TSE Health Center’s events and outreach activities and benefits from enhanced visibility through the Center’s various communication channels.

Based in a long-term vision, the research projects conducted rely on regular interactions between TSE researchers and bioMérieux teams. This collaboration fosters the exchange of expertise and helps advance research on antibiotic resistance. Academics involved in the initiative also engage with the Antimicrobial Resistance Working Group of the Health Sector Strategic Committee (CSF) of the National Industry Committee (CNI), thereby strengthening the links between research, industry, and public health issues.